Benchmark's interim results confirm the limited damage of a Salmosan generic launching in Chile this year. However, this story remains so much more. With the new Breeding & Genetics division (BBG) leading from the front, the opportunities for this broad-based animal health-to-sustainability science Group look set to deliver significant earnings growth.
29 Jun 2015
A clear growth path
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A clear growth path
Benchmark Holdings Plc (BMK:LON) | 43.5 0 0.0% | Mkt Cap: 321.8m
- Published:
29 Jun 2015 -
Author:
Robin Campbell -
Pages:
11
Benchmark's interim results confirm the limited damage of a Salmosan generic launching in Chile this year. However, this story remains so much more. With the new Breeding & Genetics division (BBG) leading from the front, the opportunities for this broad-based animal health-to-sustainability science Group look set to deliver significant earnings growth.